G
George V. Mazariegos
Researcher at Boston Children's Hospital
Publications - 377
Citations - 14640
George V. Mazariegos is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 63, co-authored 339 publications receiving 12863 citations. Previous affiliations of George V. Mazariegos include University of Pennsylvania & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.
Ashok Jain,Jorge Reyes,Randeep Kashyap,S. Forrest Dodson,Anthony J. Demetris,Kris Ruppert,Kareem Abu-Elmagd,Wallis Marsh,Juan Madariaga,George V. Mazariegos,David A. Geller,C. Andrew Bonham,Timothy Gayowski,Thomas V. Cacciarelli,Paulo Fontes,Thomas E. Starzl,John J. Fung +16 more
TL;DR: Significantly improved patient and graft survival has been observed over time, and graft loss from acute or chronic rejection has emerged as a rarity.
Journal ArticleDOI
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.
Anthony J. Demetris,Christopher Bellamy,Stefan G. Hubscher,Jacqueline G. O'Leary,Parmjeet Randhawa,Sandy Feng,Desley Neil,Robert B. Colvin,Geoffrey W. McCaughan,John J. Fung,A. Del Bello,Finn P. Reinholt,Hironori Haga,Oyedele Adeyi,A J Czaja,Thomas D. Schiano,Maria Isabel Fiel,Maxwell L. Smith,Mylène Sebagh,R Y Tanigawa,Funda Yilmaz,Graeme J.M. Alexander,L Baiocchi,M Balasubramanian,Ibrahim Batal,Atul K. Bhan,John C. Bucuvalas,Carlos Thadeu Schmidt Cerski,F Charlotte,M. E. de Vera,M ElMonayeri,Paulo Fontes,Emma E. Furth,Annette S. H. Gouw,Sara Hafezi-Bakhtiari,John Hart,E Honsova,Wesam Ismail,Tomoo Itoh,N C Jhala,Urmila Khettry,Goran B. Klintmalm,Stuart J. Knechtle,Takaaki Koshiba,Tomasz Kozlowski,Charles Lassman,Jan Lerut,Josh Levitsky,L Licini,R Liotta,George V. Mazariegos,Marta I. Minervini,Joseph Misdraji,Thalachallour Mohanakumar,Johan Mölne,Imad Nasser,James Neuberger,M O'Neil,O Pappo,L Petrovic,Phillip Ruiz,Ozgul Sagol,A Sanchez Fueyo,Eizaburo Sasatomi,Abraham Shaked,M. Shiller,T Shimizu,Banu Sis,Aurelio Sonzogni,Heather L. Stevenson,Swan N. Thung,Giuseppe Tisone,Athanassios C. Tsamandas,Annika Wernerson,Tong Wu,A. Zeevi,Yoh Zen +76 more
TL;DR: New recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization are included.
Journal ArticleDOI
Weaning of immunosuppression in liver transplant recipients.
George V. Mazariegos,Jorge Reyes,Ignazio R. Marino,Anthony J. Demetris,Bridget Flynn,William Irish,John McMichael,John J. Fung,Thomas E. Starzl +8 more
TL;DR: Long surviving liver transplant recipients are systematically overimmunosuppressed, Consequently, drug weaning, whether incomplete or complete, is an important management strategy providing it is done slowly under careful physician surveillance.
Journal ArticleDOI
Clinical Intestinal Transplantation: A Decade of Experience at a Single Center
Kareem Abu-Elmagd,Jorge Reyes,Geoffrey Bond,George V. Mazariegos,Tong Wu,Noriko Murase,Rakesh Sindhi,D Martin,Joanne Colangelo,Marsha Zak,Douglas Janson,Mohamed Ezzelarab,Igor Dvorchik,Maria Parizhskaya,Melvin Deutsch,Anthony J. Demetris,John J. Fung,Thomas E. Starzl +17 more
TL;DR: The survival rates after intestinal transplantation have cumulatively improved during the past decade, and with the management strategies currently under evaluation, intestinal transplant procedures have the potential to become the standard of care for patients with end-stage intestinal failure.
Journal ArticleDOI
Intestinal transplant registry report: global activity and trends.
David R. Grant,Kareem Abu-Elmagd,Kareem Abu-Elmagd,George V. Mazariegos,Rodrigo Vianna,Alan Norman Langnas,Richard S. Mangus,Douglas G. Farmer,F. Lacaille,Kishore Iyer,Thomas M. Fishbein +10 more
TL;DR: Waiting at home for IT, the use of induction immune‐suppression therapy, inclusion of a liver component and maintenance therapy with rapamycin were associated with better graft survival and case volumes have recently declined.